News

Conditioning that once worked with Pavlov’s dog does also work with an artificially induced change in nerve cell activity.

A new class of immunotherapy shows promising results for fighting the most aggressive form of skin cancer.

A gene in the brain driving anxiety symptoms has been identified by an international team of scientists. Critically, modification of the gene is shown to reduce anxiety levels, offering an exciting novel drug target for anxiety disorders.

A mobile vaccine printer, developed by MIT researchers, could be used to scale up vaccine production and help vaccines reach more people.

Scientists have shown that self-propelled, magnetic packages of yeast, or “BeerBots,” can make the beer fermentation phase go faster and cut out the need to filter the beverage.

A new study is the first to identify a damage response pathway that is distinct from the pathogen-triggered wound repair pathway.

It is not easy to make batteries cheap, efficient, durable, safe and environmentally friendly at the same time. Researchers at ETH Zurich have now succeeded in uniting all of these characteristics in zinc metal batteries.

A portable electrochemical lead ion (Pb2+) sensor based on cobalt-doped Prussian blue combining MXene material has been developed that has enormous potential for Pb2+ detection in practical applications.

Researchers at the Johns Hopkins Kimmel Cancer Center have identified a novel cell signaling pathway that potentially could be targeted in therapy for patients with aggressive pancreatic cancers.

Problems with the brain’s ability to ‘prune’ itself of unnecessary connections may underlie a wide range of mental health disorders that begin during adolescence.